Asia Pacific: In Asia Pacific, countries like China, Japan, and South Korea are witnessing a rise in demand for RNA analysis owing to the growing focus on precision medicine and personalized healthcare. The increasing investments in research and development activities are also driving market growth in these countries.
Europe: The RNA Analysis market in Europe is thriving, with the United Kingdom, Germany, and France emerging as key markets in the region. The presence of leading research institutes and pharmaceutical companies, coupled with favorable government policies, are fueling the market growth in these countries.